0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Long Struggle Continues to Find New Weapons Against an Old Foe—the Malaria Parasite

Charles Marwick
JAMA. 1990;263(20):2718. doi:10.1001/jama.1990.03440200016004.
Text Size: A A A
Published online

ABSTRACT

PROTECTION against the malaria parasite is a highly complex affair that has hindered the development of an effective vaccine against the disease.

Despite the contributions of the molecular biologist in isolating, cloning, and manufacturing, by recombinant techniques, immunologic pieces of the parasite, and the testing of one recombinant gene-cloned vaccine (which stimulated only low levels of antibody), the goal of an effective immunogen against malaria seems as far off as ever.

But if the goal remains distant, this isn't deterring a determined cadre of malaria researchers from pursuing it, if the amount and variety of research reported at a recent workshop on cellular mechanisms in malaria immunity—held by the John E. Fogarty International Center staff at the National Institutes of Health campus in Bethesda, Md—is any evidence.

Pace Picking Up  "The field is moving so rapidly, I sometimes have difficulty myself seeing what's important and what isn't," admits Peter Perlmann,

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

28 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();